J1203 – Injection, cipaglucosidase alfa-atga, 5 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1203
- Long description
- Injection, cipaglucosidase alfa-atga, 5 mg
- Short description
- Inj, cipaglucosidase, 5 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- April 1, 2024
- Last change
- April 1, 2024 – No change
Frequently asked questions
What is HCPCS code J1203?
J1203 is a HCPCS Level II code for injection, cipaglucosidase alfa-atga, 5 mg.
Does Medicare cover J1203?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1165 – Injection, phenytoin sodium, per 50 mg
- J1170 – Injection, hydromorphone, up to 4 mg
- J1171 – Injection, hydromorphone, 0.1 mg
- J1180 – Injection, dyphylline, up to 500 mg
- J1190 – Injection, dexrazoxane hydrochloride, per 250 mg
- J1200 – Injection, diphenhydramine hcl, up to 50 mg
- J1201 – Injection, cetirizine hydrochloride, 0.5 mg
- J1202 – Miglustat, oral, 65 mg
- J1205 – Injection, chlorothiazide sodium, per 500 mg
- J1212 – Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
- J1230 – Injection, methadone hcl, up to 10 mg
- J1240 – Injection, dimenhydrinate, up to 50 mg
- J1245 – Injection, dipyridamole, per 10 mg
- J1250 – Injection, dobutamine hydrochloride, per 250 mg
- J1260 – Injection, dolasetron mesylate, 10 mg
- J1265 – Injection, dopamine hcl, 40 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.